Research study Program year 2021 Source: CMS Open Payments

PoCC dose finding in Mild to Moderate AD

Research payments

$2,205,375

41 payments

Through program year 2021, $2,205,375 in research payments was reported against PoCC dose finding in Mild to Moderate AD, across 41 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..

Paid by: Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$54,487	2
2020	Research	$353,299	17
2019	Research	$1,797,589	22

Breakdown

Who paid Research payments · program years 2019–2021

Boehringer Ingelheim Pharmaceuticals, Inc. $2,205,375 41 payments

Who received the money Research payments · program years 2019–2021

Wilks And Safirstein MD PA-MD Clinical Organisation paid for research $342,110 3 payments
Galiz Research Organisation paid for research $300,976 3 payments
Premier Clinical Research Institute Organisation paid for research $203,647 3 payments
Compass Research LLC Organisation paid for research $200,921 2 payments
Citrials INC Organisation paid for research $194,912 2 payments
Axiom Research LLC Organisation paid for research $143,044 2 payments
Ani Neurology Pllc Organisation paid for research $140,836 2 payments
Memory Clinic INC Organisation paid for research $119,295 1 payment
Millennium Psychiatric Associates LLC Organisation paid for research $116,029 2 payments
Alliance For Wellness Organisation paid for research $110,822 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.